While questions and controversies remain, the information on long-term neurodevelopmental outcomes in children prenatally exposed to antidepressants is largely reassuring.
SSRI and SNRI antidepressants were not associated with an increased risk for gestational diabetes.
The current study indicates that duloxetine administered at a dose of 60 mg does not have an impact on sperm quality.
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.
Many women ask whether taking antidepressants may increase the risk for miscarriage or spontaneous abortion. Some, but not all, studies have demonstrated an increased risk of miscarriage among women who use antidepressants. However, it has [...]
While we have data to support the use of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs) and the serotonin norepinephrine reuptake inhibitors (SNRIs), during pregnancy, most studies have focused on risk of congenital [...]
Over the last decade, various studies have examined the risk of obstetric complications in women using antidepressants during pregnancy. Preeclampsia: Some studies have suggested that pregnant women taking SSRI antidepressants may be at higher [...]
While we have considerable data regarding the reproductive safety of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs), most studies have focused on the prevalence of major malformations in children with prenatal exposure to [...]
Women receiving tamoxifen for the treatment or prevention of breast cancer should be aware of possible drug-drug interactions between tamoxifen and specific antidepressant medications. Antidepressants are used widely to treat depression and anxiety disorders in [...]
While we have considerable data on the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy, most of this research focuses on the risk of congenital malformations in exposed children. We have far less [...]
